60 related articles for article (PubMed ID: 19243501)
1. A liver slice culture-based ex vivo assay to predict the outcome of antiviral therapy for chronic hepatitis C.
Chang ML; Sung KF; Sheen IS; Lin SM; Yeh CT
J Viral Hepat; 2009 May; 16(5):359-66. PubMed ID: 19243501
[TBL] [Abstract][Full Text] [Related]
2. A novel ex vivo assay of interferon-based suppression, to predict the outcome of antiviral therapy for hepatitis C.
Yeh CT; Hsu CW; Chang ML; Sheen IS; Lin SM; Lin CJ; Lin CC; Chen YC; Chen JC
J Infect Dis; 2006 May; 193(10):1365-70. PubMed ID: 16619183
[TBL] [Abstract][Full Text] [Related]
3. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
4. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
Cescon M; Grazi GL; Cucchetti A; Vetrone G; Ravaioli M; Ercolani G; Morelli MC; Piscaglia F; Tamè M; Pinna AD
Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.
Kumar D; Farrell GC; Fung C; George J
Hepatology; 2002 Nov; 36(5):1266-72. PubMed ID: 12395339
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of 24-week interferon monotherapy for type C liver cirrhosis in Japanese patients with genotype 1b and low virus load.
Arase Y; Suzuki F; Sezaki H; Kawamura Y; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Yatsuji H; Hirakawa M; Kobayashi M; Ikeda K; Kumada H
Intervirology; 2008; 51(4):265-9. PubMed ID: 18841028
[TBL] [Abstract][Full Text] [Related]
7. Dense packing of portal lymphocytes predicts favorable treatment outcome in hepatitis C.
Chang ML; Hsu CW; Huang SF; Chen TC; Lin SM; Yeh CT
Hepatogastroenterology; 2008; 55(86-87):1716-20. PubMed ID: 19102376
[TBL] [Abstract][Full Text] [Related]
8. Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
Lecube A; Hernández C; Simó R; Esteban JI; Genescà J
Am J Gastroenterol; 2007 Oct; 102(10):2189-95. PubMed ID: 17617205
[TBL] [Abstract][Full Text] [Related]
9. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.
Hanouneh IA; Feldstein AE; Lopez R; Yerian L; Pillai A; Zein CO; Zein NN
Clin Gastroenterol Hepatol; 2008 May; 6(5):584-9. PubMed ID: 18455698
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Bartolomé J; Carreño V
Clin Infect Dis; 2006 Nov; 43(10):1277-83. PubMed ID: 17051492
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.
Sanefuji K; Kayashima H; Iguchi T; Sugimachi K; Yamashita Y; Yoshizumi T; Soejima Y; Nishizaki T; Taketomi A; Maehara Y
J Surg Oncol; 2009 Jan; 99(1):32-7. PubMed ID: 18985618
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome.
de Almeida AJ; Campos-de-Magalhães M; Brandão-Mello CE; de Oliveira RV; do Espirito-Santo MP; Yoshida CF; Lampe E
Hepatogastroenterology; 2009; 56(90):429-36. PubMed ID: 19579615
[TBL] [Abstract][Full Text] [Related]
14. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C.
Miyaaki H; Ichikawa T; Nakao K; Takeshita S; Shibata H; Ozawa E; Akiyama M; Miuma S; Eguchi K
Intervirology; 2008; 51(6):394-9. PubMed ID: 19258717
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
Scherzer TM; Reddy KR; Wrba F; Hofer H; Staufer K; Steindl-Munda P; Gangl A; Ferenci P
J Viral Hepat; 2008 Sep; 15(9):659-65. PubMed ID: 18637075
[TBL] [Abstract][Full Text] [Related]
17. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
[TBL] [Abstract][Full Text] [Related]
18. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
20. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.
Berenguer M; Aguilera V; Prieto M; Ortiz C; Rodríguez M; Gentili F; Risalde B; Rubin A; Cañada R; Palau A; Rayón JM
Liver Transpl; 2009 Jul; 15(7):738-46. PubMed ID: 19562707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
